Skip to main content

UBS Group AG

Position in CSTL — Castle Biosciences Inc

CIK 1610520 ZURICH, V8

Position in CSTL

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,206,950
-$4,311,908 QoQ
Shares Held
49,163
-65.3% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Derivatives in CSTL

reported options exposure · as of Dec 31, 2024
CallValue
$703,560
CallShares
26,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,683,964,878 across 46 Diagnostics & Research names. CSTL ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CSTL

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,206,950 49,163
2025-12-31 $5,518,858 141,873
2025-09-30 $6,634,311 291,362
2025-06-30 $7,429,775 363,848
2025-03-31 $976,154 48,759
2024-12-31 $703,560 26,400
2024-12-31 $21,655,789 812,600
2024-09-30 $1,543,900 54,134
2024-09-30 $752,928 26,400
2024-06-30 $1,060,699 48,723
2024-03-31 $1,214,771 54,843
2023-12-31 $895,073 41,477
2023-09-30 $304,711 18,041
2023-06-30 $237,424 17,305
2023-03-31 $240,241 10,574
2022-12-31 $246,816 10,485
2022-09-30 $185,975 7,131
2022-06-30 $356,138 16,225
2022-03-31 $172,666 3,849
2021-12-31 $445,760 10,398
2021-09-30 $83,523 1,256
2021-06-30 $49,864 680
2021-03-31 $628,256 9,177
2020-12-31 $748,251 11,143
2020-12-31 $1,007,250 15,000
2020-12-31 $1,007,250 15,000
2020-09-30 $206,931 4,022
2020-06-30 $235,599 6,251
2020-03-31 $199,220 6,683